I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
van Brummelen, Emilie M.J.
~ 100
results:
Search for persons
X
Format
Online
Mediatypes
Articles (Online)
Bookchapter (Online)
OpenAccess-fulltext
Thesis (Online)
Sorted by: Relevance
Sorted by: Year
?
1
Integration of healthy volunteers in early phase clinical t..:
Radanovic, Igor
;
Klarenbeek, Naomi
;
Rissmann, Robert
...
Frontiers in Oncology. 12 (2022) - p. , 2022
Link:
https://doi.org/10.3389/..
?
2
Safety and pharmacokinetics of multiple dosing with inhalab..:
Thijssen, Eva
;
den Heijer, Jonas M.
;
Puibert, David
...
Parkinsonism & Related Disorders. 97 (2022) - p. 84-90 , 2022
Link:
https://doi.org/10.1016/..
?
3
A phase I, randomized, double‐blind, placebo‐controlled, si..:
Hijma, Hemme J.
;
van Brummelen, Emilie M. J.
;
Siebenga, Pieter S.
.
Clinical and Translational Science. 15 (2021) 4 - p. 981-993 , 2021
Link:
https://doi.org/10.1111/..
?
4
First‐in‐human trial to assess the safety, tolerability, ph..:
Moss, Laurence M.
;
Berends, Cecile L.
;
van Brummelen, Emilie M. J.
...
British Journal of Clinical Pharmacology. 88 (2021) 1 - p. 103-114 , 2021
Link:
https://doi.org/10.1111/..
?
5
Phase 1 clinical trial of losmapimod in facioscapulohumeral..:
Mellion, Michelle L.
;
Ronco, Lucienne
;
Berends, Cecile L.
...
British Journal of Clinical Pharmacology. 87 (2021) 12 - p. 4658-4669 , 2021
Link:
https://doi.org/10.1111/..
?
6
Healthy volunteers in first‐in‐human oncology drug developm..:
de las Heras, Begoña
;
Bouyoucef‐Cherchalli, Dalila
;
Reeve, Lesley
...
British Journal of Clinical Pharmacology. 88 (2021) 4 - p. 1773-1784 , 2021
Link:
https://doi.org/10.1111/..
?
7
Touchscreen-based finger tapping: Repeatability and configu..:
Makai-Bölöni, Soma
;
Thijssen, Eva
;
van Brummelen, Emilie M. J.
...
PLOS ONE. 16 (2021) 12 - p. e0260783 , 2021
Link:
https://doi.org/10.1371/..
?
8
Phase I study of lapatinib plus trametinib in patients with..:
Huijberts, Sanne C. F. A.
;
van Geel, Robin M. J. M.
;
van Brummelen, Emilie M. J.
...
Cancer Chemotherapy and Pharmacology. 85 (2020) 5 - p. 917-930 , 2020
Link:
https://doi.org/10.1007/..
?
9
Quantification of tremor using consumer product acceleromet..:
van Brummelen, Emilie M. J.
;
Ziagkos, Dimitrios
;
de Boon, Wadim M. I.
...
Journal of Clinical Movement Disorders. 7 (2020) 1 - p. , 2020
Link:
https://doi.org/10.1186/..
?
10
First-in-human administration of a live-attenuated RSV vacc..:
Verdijk, Pauline
;
van der Plas, Johan L.
;
van Brummelen, Emilie M.J.
...
Vaccine. 38 (2020) 39 - p. 6088-6095 , 2020
Link:
https://doi.org/10.1016/..
?
11
Phase 1 study of the pan-HER inhibitor dacomitinib plus the..:
van Geel, Robin M. J. M.
;
van Brummelen, Emilie M. J.
;
Eskens, Ferry A. L. M.
...
British Journal of Cancer. 122 (2020) 8 - p. 1166-1174 , 2020
Link:
https://doi.org/10.1038/..
?
12
Phase I Study of Afatinib and Selumetinib in Patients with ..:
Brummelen, Emilie M.J.
;
Huijberts, Sanne
;
Herpen, Carla
...
The Oncologist. 26 (2020) 4 - p. 290-e545 , 2020
Link:
https://doi.org/10.1002/..
?
13
A phase Ib study of GSK3052230, an FGF ligand trap in combi..:
van Brummelen, Emilie M. J.
;
Levchenko, Evgeny
;
Dómine, Manuel
...
Investigational New Drugs. 38 (2019) 2 - p. 457-467 , 2019
Link:
https://doi.org/10.1007/..
?
14
Prevalent levels of RSV serum neutralizing antibodies in he..:
Van Der Plas, Johan L.
;
Verdijk, Pauline
;
Van Brummelen, Emilie M. J.
...
Human Vaccines & Immunotherapeutics. 16 (2019) 6 - p. 1322-1326 , 2019
Link:
https://doi.org/10.1080/..
?
15
89Zr-labeled CEA-targeted IL-2 variant immunocytokine in pa..:
van Brummelen, Emilie M.J.
;
Huisman, Marc C.
;
de Wit-van der Veen, Linda J.
...
Oncotarget. 9 (2018) 37 - p. 24737-24749 , 2018
Link:
https://doi.org/10.18632..
1-15